BioProtect Ltd., a technology platform company, provides innovative bioabsorbable spacers. The technology may suit various clinical applications for radiation oncology protection.
Our vision is to become a world leader in providing a unique spacer to protect healthy organs during radiation therapy treatment.
BioProtect’s first application commercially available in Europe is the BioProtect Balloon Implant™ System spacer. A spacer to protect healthy tissue in patients receiving radiotherapy for prostate cancer. The BioProtect Balloon Implant™ System spacer proved to reduce undesirable and costly side effects, reduce treatment cost, and improve patients’ quality of life. The company is currently undergoing the FDA regulatory process approval and preparing for associated commercial scale-up. BioProtect is ISO 13485:2016 certified and has the CE Mark for its BioProtect Balloon Implant™ System.